Revenue Expected to be Approximately $107.5 Million; Gross Orders Expected to be Approximately $67 Million Management Reiterates Guidance for FY2016 SUNNYVALE, Calif. , Jan. 11, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today preliminary product orders and revenues for the
SUNNYVALE, Calif. , Jan. 7, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2015 on January 28, 2016 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m.
SUNNYVALE, Calif. , Jan. 4, 2016 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that Joshua H. Levine , president and chief executive officer, is scheduled to present at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 12, 2016
Clinicians Gather to Foster Industry Collaboration and Discuss Best Practices in Radiation Therapy SUNNYVALE, Calif. , Dec. 17, 2015 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Accuray Exchange in Radiation Oncology (AERO™) Users' Meeting was held November 13-14,
SUNNYVALE, Calif. , Nov. 5, 2015 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the first CyberKnife ® M6™ and TomoTherapy ® Systems in Chile are now installed at Fundacion Arturo Lopez Perez (FALP) Cancer Institute in Santiago, Chile .
SUNNYVALE, Calif. , Nov. 4, 2015 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the International Chamber of Commerce International Court of Arbitration (ICC) issued an interim award in an arbitration filed by Cowealth Medical Holding Co., Ltd.
SUNNYVALE, Calif. , Nov. 3, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that a member of its management team is scheduled to present at the 24th Annual Credit Suisse Healthcare Conference in Scottsdale, Arizona on Tuesday, November 10, 2015 at 1:30pm MT / 3:30pm ET .
Excellent Treatment Outcomes for a Wide Range of Tumor Types Demonstrated by Accuray CyberKnife and TomoTherapy Systems SUNNYVALE, Calif. , Nov. 2, 2015 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that studies on the clinical use of the leading-edge CyberKnife ® and
SUNNYVALE, Calif. , Oct. 15, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that Kelly Londy , formerly chief commercial officer has been named chief operating officer of the Company effective immediately. Ms. Londy will also remain an executive vice president of the
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
